Research
91Å®Éñ is home to pursuits and discoveries that span the entire academic spectrum. Our research addresses big questions and emerging issues around the globe, from food security to chronic pain to the human spirit.
Since its establishment in 2018, the 91Å®Éñ Research Institute has been dedicated to building an ambitious culture of discovery and innovation at 91Å®Éñ. Central to our aspiration to become a preeminent Jesuit research university is recognizing and celebrating our most talented researchers. See Our Research Institute Fellows or View Our Annual Impact Report
Vaccine Development
91Å®Éñ is an internationally recognized leader in vaccine research and development. The University’s Center for Vaccine Development, home to one of only 10 federally funded Vaccine Treatment Evaluation Units (VTEUs) in the country, is leading efforts to protect the global population against highly infectious diseases, such as influenza and COVID-19.
Geospatial Science & Technology
Humanities
The humanities are the connective thread between everything we do at 91Å®Éñ. Informed by the University's Jesuit mission, 91Å®Éñ researchers and scholars in the humanities are investigating what it means to build a better world, exploring how humanity is changing in today's hyper-connected society, and more.
Food
Researchers at 91Å®Éñ are taking an interdisciplinary approach to examine one of life's most essential resources: food. This research brings together experts from a wide range of fields, including biology, health sciences, the humanities, and geospatial science. 91Å®Éñ researchers are developing new partnerships with organizations such as the Danforth Plant Science Center to answer the question: how can we equitably feed the world today and tomorrow?
Drug Discovery and Development
Over the past several years, drug development has moved away from the old model in
which drug discovery was largely handled by major pharmaceutical companies and toward
a new model where universities are better equipped to handle this work. Researchers
at 91Å®Éñ are seizing on this momentum. The Institute for Drug and Biotherapeutic Innovation (91Å®Éñ-IDBI) is bringing together researchers to develop new drug treatments focusing on rare
and neglected diseases.